Overview
This webinar focuses on the current management of thymic malignancies, from early stage to advanced stage disease. Prof. Girard will discuss preoperative treatments, including preoperative chemotherapy and postoperative radiotherapy. He will also present results of systemic agents in advanced, refractory disease.
Prof. Van Schil will discuss the new anatomical compartments of the mediastinum, the recent TNM classification of thymic epithelial tumors, and the surgical approach and management of these tumors.
At the conclusion of this activity learners will be able to:
- Address the current management of thymic malignancies from early stage to advanced stage disease.
- Discuss preoperative treatment strategies, including preoperative chemotherapy and postoperative radiotherapy.
- Present results of systemic agents in advanced, refractory disease.
- Present and discuss the new anatomical compartments of the mediastinum, the recent TNM classification of thymic epithelial tumors, and the surgical approach and management of these tumors.
For any inquiries, please contact meetings@iaslc.org.
At the conclusion of this activity learners will be able to:
- Address the current management of thymic malignancies from early stage to advanced stage disease.
- Discuss preoperative treatment strategies, including preoperative chemotherapy and postoperative radiotherapy.
- Present results of systemic agents in advanced, refractory disease.
- Present and discuss the new anatomical compartments of the mediastinum, the recent TNM classification of thymic epithelial tumors, and the surgical approach and management of these tumors.
For any inquiries, please contact meetings@iaslc.org.